Assignee
AURINIA PHARMACEUTICALS INC
CA·7 granted patents·13 pending applications·20 citations·filing 2013–2025
Top patents by PatentIndex Score
20 records- 0190US10973871B2Ophthalmic compositionsAURINIA PHARMACEUTICALS INC·Filed 2019·Granted Apr 13, 2021·3 cites·15 claims
- 0289US9765119B2Cyclosporine analogue mixtures and their use as immunomodulating agentsAURINIA PHARMACEUTICALS INC·Filed 2015·Granted Sep 19, 2017·4 cites·25 claims
- 0386US10472394B2Cyclosporine analogue mixtures and their use as immunomodulating agentsAURINIA PHARMACEUTICALS INC·Filed 2017·Granted Nov 12, 2019·2 cites·25 claims
- 0484US10265375B2Ophthalmic compositionsAURINIA PHARMACEUTICALS INC·Filed 2015·Granted Apr 23, 2019·4 cites·29 claims
- 0582USRE48226ECyclosporine analogue mixtures and their use as immunomodulating agentsAURINIA PHARMACEUTICALS INC·Filed 2014·Granted Sep 29, 2020·1 cites·29 claims
- 0675US10286036B2Protocol for treatment of lupus nephritisAURINIA PHARMACEUTICALS INC·Filed 2017·Granted May 14, 2019·6 cites·13 claims
- 0773US2021338769A1Ophthalmic compositionsAURINIA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0868US2014370082A1Cyclosporine analogue mixtures and their use as immunomodulating agentsAURINIA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0967US2014142277A1Cyclosporine analogue mixtures and their use as immunomodulating agentsAURINIA PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1066US2023381271A1Protocol to minimize calcineurin inhibitor nephrotoxicityAURINIA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1165US11622991B2Protocol for treatment of lupus nephritisAURINIA PHARMACEUTICALS INC·Filed 2022·Granted Apr 11, 2023·0 cites·27 claims
- 1265US2014235819A1Deuterated Cyclosporine Analogs and Methods of Making the SameAURINIA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1363US2014249092A1Cyclosporin analog formulationsAURINIA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1463US2024077469A1Protocol to minimize calcineurin inhibitor nephrotoxicityAURINIA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1562US2025042970A1B cell activating factor (baff)-a proliferation inducing ligand (april) dual inhibitorsAURINIA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1660US2025205303A1Protocol for treatment of lupus nephritisAURINIA PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1757US2019224275A1Protocol for treatment of lupus nephritisAURINIA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1849US2014288266A1Synthesis of Cyclosporin AnalogsAURINIA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1946US2023183293A1Methods of treating or preventing coronavirus infectionAURINIA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2040US2015202150A1Topical Drug Delivery System for Ophthalmic UseAURINIA PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AURINIA PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →